Alpha Teknova (NASDAQ:TKNO) Trading Up 22.5% – Time to Buy?

Alpha Teknova, Inc. (NASDAQ:TKNOGet Free Report) shares shot up 22.5% during trading on Monday . The stock traded as high as $9.68 and last traded at $9.85. 131,387 shares changed hands during mid-day trading, a decline of 37% from the average session volume of 207,518 shares. The stock had previously closed at $8.04.

Alpha Teknova Price Performance

The business has a 50-day moving average of $8.12 and a 200 day moving average of $6.05. The company has a debt-to-equity ratio of 0.12, a current ratio of 4.73 and a quick ratio of 3.94.

Alpha Teknova (NASDAQ:TKNOGet Free Report) last issued its earnings results on Thursday, November 7th. The company reported ($0.15) earnings per share for the quarter, missing analysts’ consensus estimates of ($0.11) by ($0.04). Alpha Teknova had a negative return on equity of 35.30% and a negative net margin of 87.17%. The firm had revenue of $9.58 million for the quarter, compared to analyst estimates of $9.30 million. During the same period in the previous year, the company earned ($0.34) earnings per share. Analysts expect that Alpha Teknova, Inc. will post -0.58 EPS for the current fiscal year.

Institutional Inflows and Outflows

A number of hedge funds have recently made changes to their positions in the business. China Universal Asset Management Co. Ltd. bought a new position in Alpha Teknova in the 4th quarter valued at about $94,000. Whalen Wealth Management Inc. purchased a new position in Alpha Teknova during the 4th quarter worth $240,000. State Street Corp grew its stake in shares of Alpha Teknova by 249.3% in the 3rd quarter. State Street Corp now owns 76,645 shares of the company’s stock worth $371,000 after acquiring an additional 54,700 shares in the last quarter. Geode Capital Management LLC lifted its position in shares of Alpha Teknova by 24.4% during the third quarter. Geode Capital Management LLC now owns 188,173 shares of the company’s stock valued at $911,000 after purchasing an additional 36,914 shares in the last quarter. Finally, Point72 Asset Management L.P. purchased a new position in Alpha Teknova during the third quarter worth about $1,483,000. 13.81% of the stock is currently owned by institutional investors and hedge funds.

About Alpha Teknova

(Get Free Report)

Alpha Teknova, Inc produces critical reagents for the research, discovery, development, and commercialization of novel therapies, vaccines, and molecular diagnostics in the United States and internationally. The company offers pre-poured media plates for cell growth and cloning; liquid cell culture media and supplements for cellular expansion; and molecular biology reagents for sample manipulation, resuspension, and purification.

Featured Stories

Receive News & Ratings for Alpha Teknova Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Alpha Teknova and related companies with MarketBeat.com's FREE daily email newsletter.